AI assistant
CONMED Corp — Director's Dealing 2014
Jun 3, 2014
31971_dirs_2014-06-03_dae46f02-bdb6-4f16-a698-a1bf03737534.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-06-01
Reporting Person: SHALLISH ROBERT D JR (EVP, Finance, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 46090 | Direct |
| 2014-06-01 | Common Stock | F | 289 | $44.90 | Disposed | 45801 | Direct |
| 2014-06-01 | Common Stock | M | 1200 | — | Acquired | 47001 | Direct |
| 2014-06-01 | Common Stock | F | 433 | $44.90 | Disposed | 46568 | Direct |
| 2014-06-01 | Common Stock | M | 1200 | — | Acquired | 47768 | Direct |
| 2014-06-01 | Common Stock | F | 433 | $44.90 | Disposed | 47335 | Direct |
| 2014-06-01 | Common Stock | M | 1200 | — | Acquired | 48535 | Direct |
| 2014-06-01 | Common Stock | F | 433 | $44.90 | Disposed | 48102 | Direct |
| 2014-06-01 | Common Stock | M | 1400 | — | Acquired | 49502 | Direct |
| 2014-06-01 | Common Stock | F | 505 | $44.90 | Disposed | 48997 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2020-06-01 | Common Stock (1200) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2021-06-01 | Common Stock (1200) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2022-06-01 | Common Stock (1200) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 1400 | Disposed | 2023-06-01 | Common Stock (1400) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | A | 4550 | Acquired | 2024-06-01 | Common Stock (4550) | Direct |
| 2014-06-01 | Sars (Stock Appreciation Rights) | $44.90 | A | 9750 | Acquired | 2024-06-01 | Common Stock (9750) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.